(±) 8 (9) -EpETE
Eicosapentaenoic acid (EPA) is converted to epoxyeicosatetraenoic acids (EpETEs) by several cytochrome P450 isoforms. The major product of this epoxygenase pathway, (±) 17 (18) -EpETE, relaxes vascular and airway smooth muscle by activating large conductance Ca2+-activated K+ (BKCa) channels by directly interacting with BKα channel subunits. (±) 8 (9) -EpETE is an epoxygenase pathway product produced from EPA by CYP450 both in vitro and in vivo.
Product Specifications
CAS Number
851378-93-3
Product Name Alternative
(±) 8,9-EEQ; (±) 8,9-epoxy Eicosatetraenoic acid
UNSPSC
12352005
Target
Angiotensin-converting Enzyme (ACE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/racemic-8-9-epete.html
Smiles
CC/C=C\C/C=C\C/C=C\CC1C(C/C=C\CCCC(O)=O)O1
Molecular Formula
C20H30O3
Molecular Weight
318.45
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
ACTH (Adrenocorticotrophic Hormone) (Pituitary Marker) (rCLIP/1407), CF640R conjugate, 0.1mg/mL
Cyclin A2 (S- & G2-phase Cyclin) (CCNA2/2333), CF594 conjugate, 0.1mg/mL
Beta Catenin (p120) (Rabbit PAb), CF488A conjugate, 0.1mg/mL
alpha Synuclein (SNCA) (NACP140) Goat Polyclonal Antibody
